Effects of cytokine gene therapy on particulate-induced inflammation in the murine air pouch

S. Sud, S. Y. Yang, Christopher H Evans, P. D. Robbins, P. H. Wooley

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Retroviral vectors encoding the human IL-1 antagonist (IL-1Ra) gene and the human tumor necrosis factor soluble receptor (sTNF-R) gene were investigated using an in vivo model of the inflammatory response to orthopedic wear debris. Air pouches established in BALB/c mice were injected with polymethylmethacrylate (PMMA) particles to provoke an inflammatory reaction, and infected with retroviral vectors expressing IL-1Ra, sTNF-R or a LacZ marker gene. Pouch membranes and fluids were harvested after 48 or 72 hours for analyses. Positive PCR reactions for Neo genes were observed specifically in DNA extracted from the membrane of retroviral-infected pouches. ELISA assays revealed the presence of human IL-1Ra in pouch fluid from DFG-IRAP-Neo transduced mice, but not control animals. Histological evaluation indicated that the IL-1Ra gene transfer was associated with markedly decreased inflammation in the model, with resolution of the edematous phase of the reaction, decreased pouch fluid accumulation, and lowered macrophage influx. The data suggest that the air pouch model represents a useful tool to evaluate gene therapy, and demonstrate that IL-1Ra gene therapy may be an appropriate therapeutic approach to inflammation.

Original languageEnglish (US)
Pages (from-to)361-372
Number of pages12
JournalInflammation
Volume25
Issue number6
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Interleukin 1 Receptor Antagonist Protein
Genetic Therapy
Air
Cytokines
Inflammation
Genes
vpr Genes
Lac Operon
Membranes
Tumor Necrosis Factor Receptors
Polymethyl Methacrylate
Interleukin-1
Orthopedics
Enzyme-Linked Immunosorbent Assay
Macrophages
Polymerase Chain Reaction
DNA

Keywords

  • Air pouch
  • Gene therapy
  • IL-1Ra
  • PMMA

ASJC Scopus subject areas

  • Cell Biology
  • Immunology
  • Medicine(all)

Cite this

Effects of cytokine gene therapy on particulate-induced inflammation in the murine air pouch. / Sud, S.; Yang, S. Y.; Evans, Christopher H; Robbins, P. D.; Wooley, P. H.

In: Inflammation, Vol. 25, No. 6, 2001, p. 361-372.

Research output: Contribution to journalArticle

Sud, S. ; Yang, S. Y. ; Evans, Christopher H ; Robbins, P. D. ; Wooley, P. H. / Effects of cytokine gene therapy on particulate-induced inflammation in the murine air pouch. In: Inflammation. 2001 ; Vol. 25, No. 6. pp. 361-372.
@article{1da9b4be25fd45f29be26db7b2119ac8,
title = "Effects of cytokine gene therapy on particulate-induced inflammation in the murine air pouch",
abstract = "Retroviral vectors encoding the human IL-1 antagonist (IL-1Ra) gene and the human tumor necrosis factor soluble receptor (sTNF-R) gene were investigated using an in vivo model of the inflammatory response to orthopedic wear debris. Air pouches established in BALB/c mice were injected with polymethylmethacrylate (PMMA) particles to provoke an inflammatory reaction, and infected with retroviral vectors expressing IL-1Ra, sTNF-R or a LacZ marker gene. Pouch membranes and fluids were harvested after 48 or 72 hours for analyses. Positive PCR reactions for Neo genes were observed specifically in DNA extracted from the membrane of retroviral-infected pouches. ELISA assays revealed the presence of human IL-1Ra in pouch fluid from DFG-IRAP-Neo transduced mice, but not control animals. Histological evaluation indicated that the IL-1Ra gene transfer was associated with markedly decreased inflammation in the model, with resolution of the edematous phase of the reaction, decreased pouch fluid accumulation, and lowered macrophage influx. The data suggest that the air pouch model represents a useful tool to evaluate gene therapy, and demonstrate that IL-1Ra gene therapy may be an appropriate therapeutic approach to inflammation.",
keywords = "Air pouch, Gene therapy, IL-1Ra, PMMA",
author = "S. Sud and Yang, {S. Y.} and Evans, {Christopher H} and Robbins, {P. D.} and Wooley, {P. H.}",
year = "2001",
doi = "10.1023/A:1012898513512",
language = "English (US)",
volume = "25",
pages = "361--372",
journal = "Inflammation",
issn = "0360-3997",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Effects of cytokine gene therapy on particulate-induced inflammation in the murine air pouch

AU - Sud, S.

AU - Yang, S. Y.

AU - Evans, Christopher H

AU - Robbins, P. D.

AU - Wooley, P. H.

PY - 2001

Y1 - 2001

N2 - Retroviral vectors encoding the human IL-1 antagonist (IL-1Ra) gene and the human tumor necrosis factor soluble receptor (sTNF-R) gene were investigated using an in vivo model of the inflammatory response to orthopedic wear debris. Air pouches established in BALB/c mice were injected with polymethylmethacrylate (PMMA) particles to provoke an inflammatory reaction, and infected with retroviral vectors expressing IL-1Ra, sTNF-R or a LacZ marker gene. Pouch membranes and fluids were harvested after 48 or 72 hours for analyses. Positive PCR reactions for Neo genes were observed specifically in DNA extracted from the membrane of retroviral-infected pouches. ELISA assays revealed the presence of human IL-1Ra in pouch fluid from DFG-IRAP-Neo transduced mice, but not control animals. Histological evaluation indicated that the IL-1Ra gene transfer was associated with markedly decreased inflammation in the model, with resolution of the edematous phase of the reaction, decreased pouch fluid accumulation, and lowered macrophage influx. The data suggest that the air pouch model represents a useful tool to evaluate gene therapy, and demonstrate that IL-1Ra gene therapy may be an appropriate therapeutic approach to inflammation.

AB - Retroviral vectors encoding the human IL-1 antagonist (IL-1Ra) gene and the human tumor necrosis factor soluble receptor (sTNF-R) gene were investigated using an in vivo model of the inflammatory response to orthopedic wear debris. Air pouches established in BALB/c mice were injected with polymethylmethacrylate (PMMA) particles to provoke an inflammatory reaction, and infected with retroviral vectors expressing IL-1Ra, sTNF-R or a LacZ marker gene. Pouch membranes and fluids were harvested after 48 or 72 hours for analyses. Positive PCR reactions for Neo genes were observed specifically in DNA extracted from the membrane of retroviral-infected pouches. ELISA assays revealed the presence of human IL-1Ra in pouch fluid from DFG-IRAP-Neo transduced mice, but not control animals. Histological evaluation indicated that the IL-1Ra gene transfer was associated with markedly decreased inflammation in the model, with resolution of the edematous phase of the reaction, decreased pouch fluid accumulation, and lowered macrophage influx. The data suggest that the air pouch model represents a useful tool to evaluate gene therapy, and demonstrate that IL-1Ra gene therapy may be an appropriate therapeutic approach to inflammation.

KW - Air pouch

KW - Gene therapy

KW - IL-1Ra

KW - PMMA

UR - http://www.scopus.com/inward/record.url?scp=0035206031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035206031&partnerID=8YFLogxK

U2 - 10.1023/A:1012898513512

DO - 10.1023/A:1012898513512

M3 - Article

VL - 25

SP - 361

EP - 372

JO - Inflammation

JF - Inflammation

SN - 0360-3997

IS - 6

ER -